SCHEMBL9454

SCHEMBL9454

ClCCCc1ncc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9846593 0.93 TBXAS1 (0.58)
SCHEMBL27748532 0.91 TBXAS1 (0.56)
Hydrochloric Acid SCHEMBL8117523 0.90 TBXAS1 (0.62)
SCHEMBL9067 0.88
SCHEMBL3431746 0.88 TBXAS1 (0.66)
SCHEMBL9777191 0.88 TBXAS1 (0.60)
Hydrochloric Acid SCHEMBL4720278 0.86
SCHEMBL28062565 0.86 TBXAS1 (0.69)
SCHEMBL503743 0.86 TBXAS1 (0.69)
SCHEMBL285224 0.83 TERT (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112174938-A 4-indole-2-aminopyrimidine compounds and application thereof 浙江工业大学 2021-01-05 CN claimed
CN-109999769-A A kind of preparation method of the functional solid phase carrier for efficient separating Tryptophan enantiomer 常州大学 2019-07-12 CN claimed
CN-112174938-A 4-indole-2-aminopyrimidine compounds and application thereof 浙江工业大学 2021-01-05 CN disclosed
CN-109999769-A A kind of preparation method of the functional solid phase carrier for efficient separating Tryptophan enantiomer 常州大学 2019-07-12 CN disclosed
EP-1330452-A2 PYRAZINE DERIVATIVES AS MODULATORS OF TYROSINE KINASES Ortho-McNeil Pharmaceutical, Inc. (US) 2003-07-30 EP disclosed
WO-2002024681-A2 PYRAZINE DERIVATIVES AS MODULATORS OF TYROSINE KINASES ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2002-03-28 WO disclosed
EP-1032383-A4 ANTIBACTERIAL CARBAPENEMS, COMPOSITIONS AND METHODS OF TREATMEMT MERCK & CO INC (US) 2001-11-21 EP disclosed
US-6160118-A Process for the synthesis of substituted piperazinones via Mitsunobu reaction MERCK & CO., INC. (US) 2000-12-12 US disclosed
EP-1032383-A1 ANTIBACTERIAL CARBAPENEMS, COMPOSITIONS AND METHODS OF TREATMEMT Merck & Co., Inc. (US) 2000-09-06 EP disclosed
WO-2000001678-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED PIPERAZINONES VIA MITSUNOBU REACTION MERCK & CO., INC. (US) 2000-01-13 WO disclosed
WO-1999020269-A1 ANTIBACTERIAL CARBAPENEMS, COMPOSITIONS AND METHODS OF TREATMEMT MERCK & CO., INC. (US) 1999-04-29 WO disclosed
EP-0823900-A1 QUINAZOLINE DERIVATIVES ZENECA LIMITED (GB) 1998-02-18 EP disclosed
WO-1996033980-A1 QUINAZOLINE DERIVATIVES ZENECA LIMITED (GB) 1996-10-31 WO disclosed
EP-0455909-A2 5-[1-(Imidazol)methyl]-3,3-disubstituted-2(3H) furanone derivatives MARION MERRELL DOW INC. (US) 1991-11-13 EP disclosed
US-5039691-A Anticholinergic agents MARION MERRELL DOW INC. (US) 1991-08-13 US disclosed